Your browser doesn't support javascript.
loading
Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Janeway, Katherine A; Gros, Luis; Schwartz, Stefan; Daugherty, Claire; Gallardo, Eva; Hill, Christon; Thomas, Emma; Ward, Suzanne; Rizzari, Carmelo.
Afiliação
  • Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Gros L; Vall d'Hebron Research Institute and Department of Pediatric Hematology and Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany.
  • Daugherty C; BTG International Inc., Conshohocken, PA, USA.
  • Gallardo E; Protherics Medicines Development Ltd., London, UK.
  • Hill C; BTG International Inc., Conshohocken, PA, USA.
  • Thomas E; Protherics Medicines Development Ltd., London, UK.
  • Ward S; BTG International Inc., Conshohocken, PA, USA.
  • Rizzari C; Unit of Pediatrics, Foundation IRCCS San Gerardo dei Tintori, Monza, Italy.
Pediatr Blood Cancer ; 70(12): e30662, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37795968

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2023 Tipo de documento: Article